These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 17025252)

  • 41. Tramadol SR Formulations : Pharmacokinetic Comparison of a Multiple-Units Dose (Capsule) versus a Single-Unit Dose (Tablet).
    Cnota PJ; Nowak H; Tagarro I; Erb K; Schürer M; Schulz HU; Maus J
    Clin Drug Investig; 2005; 25(7):435-43. PubMed ID: 17532685
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vitro and in vivo evaluation of a novel diltiazem hydrochloride polydispersity sustained-release system.
    Sun C; Liu H; Zhao X; He H; Pan W
    Drug Dev Ind Pharm; 2013 Jan; 39(1):62-6. PubMed ID: 22339081
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development and evaluation of a multiple-unit oral sustained release dosage form for S(+)-ibuprofen: preparation and release kinetics.
    Cox PJ; Khan KA; Munday DL; Sujja-areevath J
    Int J Pharm; 1999 Dec; 193(1):73-84. PubMed ID: 10581424
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bioavailability of ibuprofen from hot-melt extruded mini-matrices.
    De Brabander C; Vervaet C; Van Bortel L; Remon JP
    Int J Pharm; 2004 Mar; 271(1-2):77-84. PubMed ID: 15129975
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development and in vitro-in vivo relationship of controlled-release microparticles loaded with tramadol hydrochloride.
    Naeem Aamir M; Ahmad M; Akhtar N; Murtaza G; Khan SA; Shahiq-uz-Zaman ; Nokhodchi A
    Int J Pharm; 2011 Apr; 407(1-2):38-43. PubMed ID: 21241789
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro controlled drug release from loaded microspheres--dose regulation through formulation.
    Waters LJ; Pavlakis E
    J Pharm Pharm Sci; 2007; 10(4):464-72. PubMed ID: 18261368
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Novel approach for determination of correlation between in vivo and in vitro dissolution using the optimization technique.
    Ishii K; Saitou Y; Yamada R; Itai S; Nemoto M
    Chem Pharm Bull (Tokyo); 1996 Aug; 44(8):1550-5. PubMed ID: 8795273
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Investigations on mefenamic acid sustained release tablets with water-insoluble gel.
    Güngör S; Yildiz A; Ozsoy Y; Cevher E; Araman A
    Farmaco; 2003 May; 58(5):397-401. PubMed ID: 12729834
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bioavailability of ibuprofen from matrix mini-tablets based on a mixture of starch and microcrystalline wax.
    De Brabander C; Vervaet C; Görtz JP; Remon JP; Berlo JA
    Int J Pharm; 2000 Nov; 208(1-2):81-6. PubMed ID: 11203270
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preliminary evaluation of the in vitro release and in vivo absorption in rabbits of the modified-release dosage forms.
    Petrovic AA; Petricevic SM; Ristic SM; Ibric SR; Simic SS; Djuric ZR; Popovic RB
    Drug Dev Ind Pharm; 2013 Jun; 39(6):889-900. PubMed ID: 22905673
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro/in vivo correlation of prolonged release dosage forms containing diltiazem HCI.
    Caramella C; Ferrari F; Bonferoni MC; Sangalli ME; De Bernardi di Valserra M; Feletti F; Galmozzi MR
    Biopharm Drug Dispos; 1993 Mar; 14(2):143-60. PubMed ID: 8453024
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Drug release kinetics of ibuprofen coated granules and their in vitro-in vivo correlation].
    Zhao GL; Wang HC
    Yao Xue Xue Bao; 1995; 30(4):291-7. PubMed ID: 7660795
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relative bioavailability of commercially available ibuprofen oral dosage forms in humans.
    Gillespie WR; DiSanto AR; Monovich RE; Albert KS
    J Pharm Sci; 1982 Sep; 71(9):1034-8. PubMed ID: 7131270
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Stereoselective disposition of suspensions of conventional and wax-matrix sustained release ibuprofen microspheres in rats.
    Adeyeye CM; Chen FF
    Pharm Res; 1997 Dec; 14(12):1811-6. PubMed ID: 9453073
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Elevation of gastric pH with ranitidine does not affect the release characteristics of sustained release ibuprofen tablets.
    Berardi RR; Dressman JB; Elta GH; Szpunar GJ
    Biopharm Drug Dispos; 1988; 9(4):337-47. PubMed ID: 3207854
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Human pharmacokinetics of tiaprofenic acid after regular and sustained release formulations: lack of chiral inversion and stereoselective release.
    Vakily M; Jamali F
    J Pharm Sci; 1994 Apr; 83(4):495-8. PubMed ID: 8046602
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vivo evaluation of an indomethacin monolithic, extended zero-order release hard-gelatin capsule formulation based on saturated polyglycolysed glycerides.
    Vial-Bernasconi AC; Buri P; Doelker E; Beyssac E; Duchaix G; Aiache JM
    Pharm Acta Helv; 1995 Dec; 70(4):307-13. PubMed ID: 8765697
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Formulation and evaluation of bi-layer tablet of metoclopramide hydrochloride and ibuprofen.
    Shiyani B; Gattani S; Surana S
    AAPS PharmSciTech; 2008; 9(3):818-27. PubMed ID: 18612830
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Use of stable isotopes for evaluation of drug delivery systems: comparison of ibuprofen release in vivo and in vitro from two biphasic release formulations utilizing different rate-controlling polymers.
    Theis DL; Lucisano LJ; Halstead GW
    Pharm Res; 1994 Aug; 11(8):1069-76. PubMed ID: 7971703
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Use of in vitro release tests for the prediction of the in vivo behavior and the development of flucytosine controlled-release capsules.
    Bonny JD; Kyowa M
    J Pharm Sci; 1995 May; 84(5):619-23. PubMed ID: 7658354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.